Translational pediatrics
Cure8 research brief
Why This Matters
Knowing which kids need biologics after EEN could help families and clinicians plan follow-up and monitoring. Simple blood tests like complement C4 and RDW may have predictive value, if confirmed.
Who Should Pay Attention
Pediatric Crohn’s patients and their parents/caregivers, pediatric gastroenterologists, and IBD researchers interested in biomarkers and treatment pathways.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study of 75 pediatric Crohn’s patients looked for predictors of starting biologic therapy within one year after completing 8 weeks of exclusive enteral nutrition (EEN).
Researchers tested many lab measures and built a prediction model; complement C4 level and red blood cell distribution width (RDW) emerged as independent predictors associated with subsequent biologic use. The analysis separated patients into derivation and validation groups and used logistic regression to identify predictors.
The authors report higher complement C4 and RDW values were linked to greater likelihood of initiating biologics within a year after EEN-induced remission. These findings are preliminary and the paper itself notes that further experimental validation is needed.
This report is based on the study abstract and summary provided by the journal (structured content depth: abstract). If you’re a caregiver or clinician, this suggests routine blood markers might help signal which kids could progress to biologic therapy after EEN, but it does not change treatment recommendations.
Keep In Mind
This is a single study with a modest sample (n=75) and the authors state that extensive validation is still required. The article is summarized from the journal abstract; it does not report practice-changing findings on its own.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTranslational pediatrics
AuthorsWang X, Hu Y, Lou J +9 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 17, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Clinical characteristics and prognosis of infant onset inflammatory bowel disease in Chinese children: a 10-year single-center experience.
Monogenic causes (especially IL-10RA mutations) are common in infant-onset IBD and are linked to more severe disease and higher mortality; early genetic testing and consideration of HSCT may change prognosis.
Health-Related quality of life in Russian children with inflammatory bowel disease is comparable across disease types and treatment modalities
The paper suggests that HRQoL and family functioning may be similar across disease types and common treatment approaches in children with IBD, but emotional health and parental worry remain areas needing attention.
Clinical phenotypes of very early onset inflammatory bowel disease in Australian children: A single-centre retrospective study.
VEO-IBD often presents with severe, extensive disease and can include monogenic causes and early hepatobiliary complications; knowing common presentations and early management patterns helps families and clinicians plan...